1 Market Overview

1.1 Product Overview and Scope of Cell and Gene Therapy Drug Delivery Devices

1.2 Classification of Cell and Gene Therapy Drug Delivery Devices by Type

1.2.1 Overview: Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type in 2020

1.2.3 Sterile Insulin Syringe

1.2.4 Pre-Filled Syringe

1.2.5 Infusion Bags

1.3 Global Cell and Gene Therapy Drug Delivery Devices Market by Application

1.3.1 Overview: Global Cell and Gene Therapy Drug Delivery Devices Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Luxturna

1.3.3 Kymriah

1.3.4 Provenge

1.3.5 Zolgensma

1.3.6 Yescarta

1.3.7 Strimvelis

1.4 Global Cell and Gene Therapy Drug Delivery Devices Market Size & Forecast

1.5 Global Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast by Region

1.5.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Cell and Gene Therapy Drug Delivery Devices Market Size by Region, (2016-2021)

1.5.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)

1.5.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)

1.5.6 South America Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cell and Gene Therapy Drug Delivery Devices Market Drivers

1.6.2 Cell and Gene Therapy Drug Delivery Devices Market Restraints

1.6.3 Cell and Gene Therapy Drug Delivery Devices Trends Analysis

2 Company Profiles

2.1 Amgen, Inc.

2.1.1 Amgen, Inc. Details

2.1.2 Amgen, Inc. Major Business

2.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.1.4 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Amgen, Inc. Recent Developments and Future Plans

2.2 Bausch and Lomb Incorporated

2.2.1 Bausch and Lomb Incorporated Details

2.2.2 Bausch and Lomb Incorporated Major Business

2.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.2.4 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bausch and Lomb Incorporated Recent Developments and Future Plans

2.3 Becton, Dickinson and Company

2.3.1 Becton, Dickinson and Company Details

2.3.2 Becton, Dickinson and Company Major Business

2.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.3.4 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Becton, Dickinson and Company Recent Developments and Future Plans

2.4 Bluebird bio, Inc.

2.4.1 Bluebird bio, Inc. Details

2.4.2 Bluebird bio, Inc. Major Business

2.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.4.4 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Bluebird bio, Inc. Recent Developments and Future Plans

2.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.)

2.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Details

2.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business

2.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments and Future Plans

2.6 Dendreon Pharmaceuticals LLC.

2.6.1 Dendreon Pharmaceuticals LLC. Details

2.6.2 Dendreon Pharmaceuticals LLC. Major Business

2.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans

2.7 Helixmith Co., Ltd (ViroMed Co., Ltd)

2.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Details

2.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business

2.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments and Future Plans

2.8 Human Stem Cell Institute

2.8.1 Human Stem Cell Institute Details

2.8.2 Human Stem Cell Institute Major Business

2.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.8.4 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Human Stem Cell Institute Recent Developments and Future Plans

2.9 Kite Pharma, Inc.

2.9.1 Kite Pharma, Inc. Details

2.9.2 Kite Pharma, Inc. Major Business

2.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.9.4 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Kite Pharma, Inc. Recent Developments and Future Plans

2.10 Kolon Tissue Gene, inc.

2.10.1 Kolon Tissue Gene, inc. Details

2.10.2 Kolon Tissue Gene, inc. Major Business

2.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.10.4 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Kolon Tissue Gene, inc. Recent Developments and Future Plans

2.11 Novartis AG

2.11.1 Novartis AG Details

2.11.2 Novartis AG Major Business

2.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.11.4 Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Novartis AG Recent Developments and Future Plans

2.12 Orchard Therapeutics plc.

2.12.1 Orchard Therapeutics plc. Details

2.12.2 Orchard Therapeutics plc. Major Business

2.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.12.4 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Orchard Therapeutics plc. Recent Developments and Future Plans

2.13 Pfizer, Inc.

2.13.1 Pfizer, Inc. Details

2.13.2 Pfizer, Inc. Major Business

2.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.13.4 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Pfizer, Inc. Recent Developments and Future Plans

2.14 Renova Therapeutics

2.14.1 Renova Therapeutics Details

2.14.2 Renova Therapeutics Major Business

2.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.14.4 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Renova Therapeutics Recent Developments and Future Plans

2.15 Spark Therapeutics, Inc.

2.15.1 Spark Therapeutics, Inc. Details

2.15.2 Spark Therapeutics, Inc. Major Business

2.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.15.4 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Spark Therapeutics, Inc. Recent Developments and Future Plans

2.16 uniQure N.V.

2.16.1 uniQure N.V. Details

2.16.2 uniQure N.V. Major Business

2.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.16.4 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 uniQure N.V. Recent Developments and Future Plans

2.17 Vericel Corporation

2.17.1 Vericel Corporation Details

2.17.2 Vericel Corporation Major Business

2.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Solutions

2.17.4 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Vericel Corporation Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Cell and Gene Therapy Drug Delivery Devices Players Market Share

3.2.2 Top 10 Cell and Gene Therapy Drug Delivery Devices Players Market Share

3.2.3 Market Competition Trend

3.3 Cell and Gene Therapy Drug Delivery Devices Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue and Market Share by Type (2016-2021)

4.2 Global Cell and Gene Therapy Drug Delivery Devices Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2016-2021)

5.2 Cell and Gene Therapy Drug Delivery Devices Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)

6.2 North America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)

6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country

6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)

6.3.2 United States Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

6.3.3 Canada Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

6.3.4 Mexico Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)

7.2 Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)

7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country

7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)

7.3.2 Germany Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

7.3.3 France Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

7.3.5 Russia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

7.3.6 Italy Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)

8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)

8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region

8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2016-2026)

8.3.2 China Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8.3.3 Japan Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8.3.4 South Korea Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8.3.5 India Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

8.3.7 Australia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)

9.2 South America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)

9.3 South America Cell and Gene Therapy Drug Delivery Devices Market Size by Country

9.3.1 South America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)

9.3.2 Brazil Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

9.3.3 Argentina Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2026)

10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2026)

10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country

10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2026)

10.3.2 Turkey Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

10.3.4 UAE Cell and Gene Therapy Drug Delivery Devices Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Cell and Gene Therapy Drug Delivery Devices Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Region (2016-2021)

Table 5. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2021-2026)

Table 6. Amgen, Inc. Corporate Information, Head Office, and Major Competitors

Table 7. Amgen, Inc. Major Business

Table 8. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 9. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bausch and Lomb Incorporated Corporate Information, Head Office, and Major Competitors

Table 11. Bausch and Lomb Incorporated Major Business

Table 12. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 13. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Becton, Dickinson and Company Corporate Information, Head Office, and Major Competitors

Table 15. Becton, Dickinson and Company Major Business

Table 16. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 17. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Bluebird bio, Inc. Corporate Information, Head Office, and Major Competitors

Table 19. Bluebird bio, Inc. Major Business

Table 20. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 21. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Corporate Information, Head Office, and Major Competitors

Table 23. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Major Business

Table 24. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 25. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Dendreon Pharmaceuticals LLC. Corporate Information, Head Office, and Major Competitors

Table 27. Dendreon Pharmaceuticals LLC. Major Business

Table 28. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 29. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Helixmith Co., Ltd (ViroMed Co., Ltd) Corporate Information, Head Office, and Major Competitors

Table 31. Helixmith Co., Ltd (ViroMed Co., Ltd) Major Business

Table 32. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 33. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Human Stem Cell Institute Corporate Information, Head Office, and Major Competitors

Table 35. Human Stem Cell Institute Major Business

Table 36. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 37. Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Kite Pharma, Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Kite Pharma, Inc. Major Business

Table 40. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 41. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Kolon Tissue Gene, inc. Corporate Information, Head Office, and Major Competitors

Table 43. Kolon Tissue Gene, inc. Major Business

Table 44. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 45. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 47. Novartis AG Major Business

Table 48. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 49. Novartis AG Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Orchard Therapeutics plc. Corporate Information, Head Office, and Major Competitors

Table 51. Orchard Therapeutics plc. Major Business

Table 52. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 53. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Pfizer, Inc. Corporate Information, Head Office, and Major Competitors

Table 55. Pfizer, Inc. Major Business

Table 56. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 57. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Renova Therapeutics Corporate Information, Head Office, and Major Competitors

Table 59. Renova Therapeutics Major Business

Table 60. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 61. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Spark Therapeutics, Inc. Corporate Information, Head Office, and Major Competitors

Table 63. Spark Therapeutics, Inc. Major Business

Table 64. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 65. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. uniQure N.V. Corporate Information, Head Office, and Major Competitors

Table 67. uniQure N.V. Major Business

Table 68. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 69. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Vericel Corporation Corporate Information, Head Office, and Major Competitors

Table 71. Vericel Corporation Major Business

Table 72. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product and Solutions

Table 73. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Players (2019-2021)

Table 75. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players (2019-2021)

Table 76. Breakdown of Cell and Gene Therapy Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3)

Table 77. Cell and Gene Therapy Drug Delivery Devices Players Head Office, Products and Services Provided

Table 78. Cell and Gene Therapy Drug Delivery Devices Mergers & Acquisitions in the Past Five Years

Table 79. Cell and Gene Therapy Drug Delivery Devices New Entrants and Expansion Plans

Table 80. Global Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) by Type (2016-2021)

Table 81. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Type (2016-2021)

Table 82. Global Cell and Gene Therapy Drug Delivery Devices Revenue Forecast by Type (2021-2026)

Table 83. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021)

Table 84. Global Cell and Gene Therapy Drug Delivery Devices Revenue Forecast by Application (2021-2026)

Table 85. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)

Table 86. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)

Table 87. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)

Table 88. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)

Table 89. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)

Table 90. North America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)

Table 91. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)

Table 92. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)

Table 93. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)

Table 94. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)

Table 95. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)

Table 96. Europe Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)

Table 97. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)

Table 98. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)

Table 99. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)

Table 100. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)

Table 101. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2016-2021) & (USD Million)

Table 102. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)

Table 103. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)

Table 104. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)

Table 105. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)

Table 106. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)

Table 107. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)

Table 108. South America Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)

Table 109. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2016-2021) & (USD Million)

Table 110. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)

Table 111. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2016-2021) & (USD Million)

Table 112. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)

Table 113. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2016-2021) & (USD Million)

Table 114. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Cell and Gene Therapy Drug Delivery Devices Picture

Figure 2. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type in 2020

Figure 3. Sterile Insulin Syringe

Figure 4. Pre-Filled Syringe

Figure 5. Infusion Bags

Figure 6. Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application in 2020

Figure 7. Luxturna Picture

Figure 8. Kymriah Picture

Figure 9. Provenge Picture

Figure 10. Zolgensma Picture

Figure 11. Yescarta Picture

Figure 12. Strimvelis Picture

Figure 13. Global Cell and Gene Therapy Drug Delivery Devices Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Cell and Gene Therapy Drug Delivery Devices Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2016-2026)

Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region in 2020

Figure 17. North America Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Cell and Gene Therapy Drug Delivery Devices Market Drivers

Figure 23. Cell and Gene Therapy Drug Delivery Devices Market Restraints

Figure 24. Cell and Gene Therapy Drug Delivery Devices Market Trends

Figure 25. Amgen, Inc. Recent Developments and Future Plans

Figure 26. Bausch and Lomb Incorporated Recent Developments and Future Plans

Figure 27. Becton, Dickinson and Company Recent Developments and Future Plans

Figure 28. Bluebird bio, Inc. Recent Developments and Future Plans

Figure 29. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Developments and Future Plans

Figure 30. Dendreon Pharmaceuticals LLC. Recent Developments and Future Plans

Figure 31. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Developments and Future Plans

Figure 32. Human Stem Cell Institute Recent Developments and Future Plans

Figure 33. Kite Pharma, Inc. Recent Developments and Future Plans

Figure 34. Kolon Tissue Gene, inc. Recent Developments and Future Plans

Figure 35. Novartis AG Recent Developments and Future Plans

Figure 36. Orchard Therapeutics plc. Recent Developments and Future Plans

Figure 37. Pfizer, Inc. Recent Developments and Future Plans

Figure 38. Renova Therapeutics Recent Developments and Future Plans

Figure 39. Spark Therapeutics, Inc. Recent Developments and Future Plans

Figure 40. uniQure N.V. Recent Developments and Future Plans

Figure 41. Vericel Corporation Recent Developments and Future Plans

Figure 42. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Players in 2020

Figure 43. Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 44. Global Top 3 Players Cell and Gene Therapy Drug Delivery Devices Revenue Market Share in 2020

Figure 45. Global Top 10 Players Cell and Gene Therapy Drug Delivery Devices Revenue Market Share in 2020

Figure 46. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 47. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Type in 2020

Figure 48. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Type (2021-2026)

Figure 49. Global Cell and Gene Therapy Drug Delivery Devices Revenue Share by Application in 2020

Figure 50. Global Cell and Gene Therapy Drug Delivery Devices Market Share Forecast by Application (2021-2026)

Figure 51. North America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)

Figure 52. North America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)

Figure 53. North America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)

Figure 54. United States Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Canada Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Mexico Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Europe Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)

Figure 58. Europe Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)

Figure 59. Europe Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)

Figure 60. Germany Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. France Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. United Kingdom Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Russia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Italy Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)

Figure 66. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)

Figure 67. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Region (2016-2026)

Figure 68. China Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Japan Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South Korea Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. India Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Australia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. South America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)

Figure 75. South America Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)

Figure 76. South America Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)

Figure 77. Brazil Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Argentina Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Type (2016-2026)

Figure 80. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Sales Market Share by Application (2016-2026)

Figure 81. Middle East and Africa Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Country (2016-2026)

Figure 82. Turkey Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 83. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. UAE Cell and Gene Therapy Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. Methodology

Figure 86. Research Process and Data Source